Richard Nolan Townsend
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $656K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 19SEC | LXEOLexeo Therapeutics, Inc. | Sell | 3,345374,472 held (−1%) | $4.95 | $17K | -34.7% |
| Jul 1SEC | LXEOLexeo Therapeutics, Inc. | Sell | 25,947377,817 held (−6%) | $4.48 | $116K | -27.9% |
| May 20SEC | LXEOLexeo Therapeutics, Inc. | Sell | 3,342336,764 held (−1%) | $5.06 | $17K | -36.2% |
| Apr 7SEC | LXEOLexeo Therapeutics, Inc. | Sell Plan | 55,000340,106 held (−14%) | $5.69 | $313K | -43.2% |
| Feb 20SEC | LXEOLexeo Therapeutics, Inc. | Sell | 10,173392,483 held (−3%) | $6.38 | $65K | -49.4% |
| Nov 20SEC | LXEOLexeo Therapeutics, Inc. | Sell | 1,127240,991 held (−0%) | $9.27 | $10K | -65.2% |
| Oct 17SEC | LXEOLexeo Therapeutics, Inc. | Sell | 12,985242,266 held (−5%) | $8.94 | $116K | -63.9% |
| Oct 17SEC | LXEOLexeo Therapeutics, Inc. | Sell | 148242,118 held (−0%) | $9.56 | $1K | -66.2% |
- Sell
CEO Richard Nolan Townsend sold $313K of LXEO at $5.69 — pre-scheduled 10b5-1 plan sale.